A dynamic expression of EpCAM during tumor evolution has been observed in diverse sarcoma subtypes, with a correlation between high EpCAM expression and significantly poorer patient’s OS and adverse outcome [141]. The gene discussed is EPCAM; the disease is sarcoma.